Oncorad Group
PrivateLast Round
Private Equity
May 11, 2023
Total Funding Raised
$45.5M
Company Overview
Oncorad Group operates in Healthcare & Life Sciences and is based in Casablanca. Its latest recorded funding round was a Private Equity round in May 2023.
Oncorad Group is a healthcare company that operates a network of private clinics in Morocco specializing in oncology, radiology, and multidisciplinary medical services.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Telemedicine, Medical Devices, Biotechnology
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncorad Group Comparables
Compare Oncorad Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncologie et Diagnostic du Maroc | 90% | |
| CIM Santé Group | 86% | |
| Akdital | 82% |
For institutional investors. Book with your work email.
Oncorad Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | May 11, 2023 | ||||
| Growth Equity | Apr 23, 2019 |
For institutional investors. Book with your work email.
Oncorad Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDG Invest Growth | Private Equity, Growth Equity |
| STOA | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 3070% MoM, from 115 to 3.6K.
- May 21, 2026
Grew 21% QoQ, from 177 to 214 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 18, 2026
Oncorad Group performs a live remote robot-assisted radical prostatectomy during the plenary session of the European Congress of Robotic Urology Surgery (ERUS) 2026 in Morocco on Sep 9th '26.
For institutional investors. Book with your work email.
Oncorad Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oncorad Group's valuation, stock price, and market status.
Is Oncorad Group a public or private company?
Oncorad Group is a private company.
What is the current stock price of Oncorad Group?
Oncorad Group is a private company, so its shares have no public market price. Caplight tracks Oncorad Group's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oncorad Group worth (valuation)?
Valuation information for Oncorad Group is not publicly available.
Can I buy Oncorad Group stock?
Oncorad Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oncorad Group's last funding round?
Oncorad Group's most recent funding round was Private Equity on May 11, 2023.
Who are the main investors in Oncorad Group?
Key investors in Oncorad Group include CDG Invest Growth.
Will Oncorad Group IPO soon?
No public IPO plans have been announced for Oncorad Group.
How can I track Oncorad Group secondary market activity?
Caplight tracks bids, offers, and trades in Oncorad Group's shares on secondary markets.